SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

AMENDMENT NO. 15

SCHEDULE 13D/A

Information to be Included in Statements Filed Pursuant

to Rule 13d-1(a) and Amendments Thereto Filed Pursuant to Rule 13d-2(a)

Engex, Inc.

(Name of Issuer)

COMMON STOCK, $.10 PAR VALUE

(Title of Class of Securities)

292851102

(CUSIP Number)

David Selengut, Esq.

c/o Ellenoff Grossman & Schole LLP

1345 Avenue of the Americas

New York, NY 10105

(212) 370-1300

(Name, Address and Telephone Number of Person Authorized

to Receive Notices and Communications)

June 26, 2017

(Date of Event which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box. ☐

Note: schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7(b) for other parties to whom copies are to be sent.

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

SCHEDULE 13D/A

CUSIP No. 292851102

Page 2 of 7 pages

1	NAME OF REPORTING PERSON
	J. Morton Davis

2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*			(a)	☐
				(b)	☒

3	SEC USE ONLY


4	SOURCE OF FUNDS*
	See Item #3 herein

5	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)				☐


6	CITIZENSHIP OR PLACE OF ORGANIZATION
	United States

NUMBER OF SHARES BY EACH REPORTING PERSON WITH		7	SOLE VOTING POWER
			709,869

		8	SHARED VOTING POWER
			0

		9	SOLE DISPOSITIVE POWER
			709,869

		10	SHARED DISPOSITIVE POWER
			0

11	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
	1,130,204

12	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*				☐


13	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
	69.5%

14	TYPE OF REPORTING PERSON*
	IN

*SEE INSTRUCTIONS BEFORE FILLING OUT!

SCHEDULE 13D/A

CUSIP No. 292851102

Page 3 of 7 pages

1	NAME OF REPORTING PERSON
	Rosalind Davidowitz

2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*			(a)	☐
				(b)	☐

3	SEC USE ONLY


4	SOURCE OF FUNDS*
	See Item #3 herein

5	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)				☐


6	CITIZENSHIP OR PLACE OF ORGANIZATION
	United States

NUMBER OF SHARES BY EACH REPORTING PERSON WITH		7	SOLE VOTING POWER
			420,335

		8	SHARED VOTING POWER
			0

		9	SOLE DISPOSITIVE POWER
			420,335

		10	SHARED DISPOSITIVE POWER
			0

11	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
	1,130,204

12	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*				☐


13	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
	69.5%

14	TYPE OF REPORTING PERSON*
	IN

*SEE INSTRUCTIONS BEFORE FILLING OUT!

SCHEDULE 13D/A

CUSIP No. 292851102

Page 4 of 7 pages

1	NAME OF REPORTING PERSON
	Izor LLC

2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*			(a)	☐
				(b)	☒

3	SEC USE ONLY


4	SOURCE OF FUNDS*
	See Item #3 herein

5	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)				☐


6	CITIZENSHIP OR PLACE OF ORGANIZATION
	New York

NUMBER OF SHARES BY EACH REPORTING PERSON WITH		7	SOLE VOTING POWER
			167,429

		8	SHARED VOTING POWER
			0

		9	SOLE DISPOSITIVE POWER
			167,429

		10	SHARED DISPOSITIVE POWER
			0

11	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
	167,429

12	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*				☐


13	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
	10.2%

14	TYPE OF REPORTING PERSON*
	CO

*SEE INSTRUCTIONS BEFORE FILLING OUT!

Page 5 of 7 pages

J. Morton Davis, Rosalind Davidowitz and Izor LLC ("Izor”), (collectively, the "Reporting Parties") hereby amend the following Items in their statement on Schedule 13D relating to the common stock, $.10 par value ("shares") of Engex, Inc. (the "Issuer") as follows:

Item 3. is hereby amended by adding the following new paragraph thereto:

Since the previously filed Schedule 13D, Amendment No. 14, Rosalind Davidowitz used her personal funds to purchase 17,213 additional shares.

Item 4. is hereby partially amended as follows:

The purchases were for investment purposes only and not to effect any plan described in (a) - (j) of Item 4.

Item 5. (a) is hereby amended in its entirety as follows:

As of June 26, 2017, Mr. Davis may be deemed to beneficially own 1,130,204 shares (4) or 69.5% of the Issuer's shares as follows: (i) 58,854 shares owned by D.H. Blair Investment Banking Corp. ("Blair Investment"), (ii) 167,429 shares owned by Izor, (iii) 252,906 shares owned by Rosalind Davidowitz, and (iv) 651,015 shares owned directly by J. Morton Davis.

As of June 26, 2017, Rosalind Davidowitz may be deemed to beneficially own 1,130,204 shares or 69.5% of the Issuer's shares as indicated in (i) - (iv) above.(5).

As of June 26, 2017, Izor may be deemed to beneficially own 167,429 shares or 10.2% of the Issuer's shares.

Date	Action	Quantity		Price
12/20/2016	Buy		490	$	6.05
12/22/2016	Buy		445	$	6.05
12/23/2016	Buy		165	$	6.05
1/10/2017	Buy		1003	$	6.05
1/30/2017	Buy		97	$	6.05
1/30/2017	Buy		358	$	6.05
1/30/2017	Buy		500	$	6.05
1/30/2017	Buy		242	$	6.05
2/7/2017	Buy		300	$	6.00
2/14/2017	Buy		1500	$	6.00
3/3/2017	Buy		230	$	5.30
3/20/2017	Buy		100	$	5.80
3/20/2017	Buy		1000	$	5.82
3/20/2017	Buy		200	$	5.73
3/20/2017	Buy		100	$	5.99
3/24/2017	Buy		700	$	6.00
3/27/2017	Buy		300	$	6.50
3/27/2017	Buy		200	$	6.50
3/27/2017	Buy		100	$	10.00
3/28/2017	Buy		150	$	6.36
4/19/2017	Buy		250	$	7.25
4/19/2017	Buy		150	$	7.25
4/20/2017	Buy		100	$	6.90
4/20/2017	Buy		333	$	6.94
6/9/2017	Buy		500	$	8.75
6/9/2017	Buy		200	$	8.78
6/9/2017	Buy		600	$	8.55
6/9/2017	Buy		100	$	8.75
6/9/2017	Buy		100	$	9.25
6/19/2017	Buy		100	$	8.50
6/20/2017	Buy		500	$	9.25
6/20/2017	Buy		500	$	9.50
6/20/2017	Buy		100	$	9.50
6/20/2017	Buy		400	$	9.50
6/20/2017	Buy		314	$	9.27
6/20/2017	Buy		186	$	9.27
6/21/2017	Buy		893	$	9.00
6/21/2017	Buy		207	$	9.00
6/26/2017	Buy		500	$	9.50
6/26/2017	Buy		100	$	9.46
6/26/2017	Buy		100	$	9.50
6/26/2017	Buy		200	$	9.52
6/26/2017	Buy		300	$	9.50
6/26/2017	Buy		122	$	9.52
6/26/2017	Buy		78	$	9.52
6/26/2017	Buy		500	$	9.52
6/26/2017	Buy		600	$	9.53
6/26/2017	Buy		400	$	9.55
6/26/2017	Buy		300	$	9.56
6/26/2017	Buy		100	$	9.60
6/26/2017	Buy		200	$	9.60

TOTAL			17,213

All the purchases were made in the open market.

(4) Although Mr. Davis is including securities owned by Rosalind Davidowitz and Izor in the aggregate amount of shares owned by him, filing of this statement shall not be deemed an admission by J. Morton Davis that he beneficially owns the securities attributed to Rosalind Davidowitz or Izor LLC for any purpose. J. Morton Davis expressly disclaims beneficial ownership of all securities held by Rosalind Davidowitz and Izor.

(5) Although Mrs. Davidowitz is including securities owned by J. Morton Davis and Blair Investment in the aggregate amount of shares owned by her, filing of this statement shall not be deemed an admission by Mrs. Davidowitz that she beneficially owns the securities attributed to J. Morton Davis or Blair Investment for any purpose. Mrs. Davidowitz expressly disclaims beneficial ownership of all securities held by J. Morton Davis and Blair Investment.

Page 6 of 7 pages

SIGNATURES

After reasonable inquiry and to the best of my knowledge and belief, we certify that the information set forth in this statement is true, complete and correct.

	Date:	June 30, 2017
		New York, New York

		/s/ J. Morton Davis
		J. Morton Davis

	Date:	June 30, 2017
		New York, New York

		/s/ Rosalind Davidowitz
		Rosalind Davidowitz

	Date:	June 30, 2017
		New York, New York

		Izor LLC

		/s/ Rosalind Davidowitz
		Rosalind Davidowitz
		Sole Member

Page 7 of 7 pages

ENGEX INC SC 13D/A